
Pharmagreen Biotech Inc. – OTC:PHBI
Pharmagreen Biotech stock price today
Pharmagreen Biotech stock price monthly change
Pharmagreen Biotech stock price quarterly change
Pharmagreen Biotech stock price yearly change
Pharmagreen Biotech key metrics
Market Cap | 2.95M |
Enterprise value | 2.42M |
P/E | -2.19 |
EV/Sales | N/A |
EV/EBITDA | -2.61 |
Price/Sales | N/A |
Price/Book | -1.17 |
PEG ratio | -0.02 |
EPS | N/A |
Revenue | 4.05K |
EBITDA | -349.67K |
Income | -583.78K |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -8621.15% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePharmagreen Biotech stock price history
Pharmagreen Biotech stock forecast
Pharmagreen Biotech financial statements
Mar 2023 | 963 | -204.41K | -21226.79% |
---|---|---|---|
Jun 2023 | 597 | -162.90K | -27287.27% |
Sep 2023 | 1.43K | -178.51K | -12414.05% |
Mar 2024 | 1.05K | -37.95K | -3587.43% |
Mar 2023 | 162988 | 2.15M | 1319.83% |
---|---|---|---|
Jun 2023 | 140313 | 2.29M | 1633.03% |
Sep 2023 | 121567 | 2.30M | 1894.37% |
Mar 2024 | 103810 | 2.41M | 2323.57% |
Mar 2023 | -34.26K | 0 | 18.84K |
---|---|---|---|
Jun 2023 | 7.51K | 0 | 17.69K |
Sep 2023 | -27.58K | 0 | -589 |
Mar 2024 | -26.51K | 0 | 28.03K |
Pharmagreen Biotech other data
Insider | Compensation |
---|---|
Mr. Terry Kwan B.Com., C.A., CPA (1948) Principal Accounting Officer | $94,980 |
Mr. Peter Wojcik B.A. (1972) Pres, Chief Executive Officer, Sec., Treasurer & Director | $94,980 |
-
What's the price of Pharmagreen Biotech stock today?
One share of Pharmagreen Biotech stock can currently be purchased for approximately $0.
-
When is Pharmagreen Biotech's next earnings date?
Unfortunately, Pharmagreen Biotech's (PHBI) next earnings date is currently unknown.
-
Does Pharmagreen Biotech pay dividends?
No, Pharmagreen Biotech does not pay dividends.
-
How much money does Pharmagreen Biotech make?
Pharmagreen Biotech has a market capitalization of 2.95M.
-
What is Pharmagreen Biotech's stock symbol?
Pharmagreen Biotech Inc. is traded on the OTC under the ticker symbol "PHBI".
-
What is Pharmagreen Biotech's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Pharmagreen Biotech?
Shares of Pharmagreen Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Pharmagreen Biotech's key executives?
Pharmagreen Biotech's management team includes the following people:
- Mr. Terry Kwan B.Com., C.A., CPA Principal Accounting Officer(age: 77, pay: $94,980)
- Mr. Peter Wojcik B.A. Pres, Chief Executive Officer, Sec., Treasurer & Director(age: 53, pay: $94,980)
-
When Pharmagreen Biotech went public?
Pharmagreen Biotech Inc. is publicly traded company for more then 7 years since IPO on 15 Aug 2018.
-
What is Pharmagreen Biotech's official website?
The official website for Pharmagreen Biotech is pharmagreen.ca.
-
Where are Pharmagreen Biotech's headquarters?
Pharmagreen Biotech is headquartered at 2987 Blackbear Court, Coquitlam, BC.
-
How can i contact Pharmagreen Biotech?
Pharmagreen Biotech's mailing address is 2987 Blackbear Court, Coquitlam, BC and company can be reached via phone at +7 028039404.
Pharmagreen Biotech company profile:

Pharmagreen Biotech Inc.
pharmagreen.caOTC
0
Drug Manufacturers—Specialty & Generic
Healthcare
Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.
Coquitlam, BC V3E 3A2
CIK: 0001435181
ISIN: US71716C1099
CUSIP: 71716C109